Kathryn C. Zoon, Director at Emergent BioSolutions Inc. (EBS), sold 2,000 shares at $130.27 ($261K) on 2020-08-10, disclosed to the SEC on 2020-08-11.
Open-market sale of $261k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.27 | 1,000 | $130K | 50.0% |
| 2 | $130.27 | 1,000 | $130K | 50.0% |
| Total | $130.27 avg | 2,000 | $261K | 100% |
| Filing → |
| EBS | SELL | 2025-03-12 | $115K | — | Filing → |
| EBS | SELL | 2024-06-06 | $61K | — | Filing → |
| EBS | SELL | 2024-05-31 | $8K | — | Filing → |